App aims to ease cancer treatment side effects
NCT ID NCT06938945
First seen Mar 19, 2026 · Last updated May 14, 2026 · Updated 7 times
Summary
This study tests whether a smartphone app that lets liver cancer patients regularly report their symptoms can improve their quality of life during immunotherapy. 500 adults with liver cancer will either use the app to get personalized advice and alerts or receive standard care. The goal is to see if digital monitoring helps patients manage symptoms and communicate better with their healthcare team.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China Center for Health Development Studies, Peking University
RECRUITINGHaidian, Beijing Municipality, 100191, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.